Kiniksa Pharmaceuticals International PLCNASDAQ:KNSA
- LAST PRICE21.0900
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots18.0000/ 1
- Ask / Lots26.5000/ 10
- Open / Previous Close--- / 21.0900
- Day Range---
- 52 Week Range
- Volume90
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | KNSA |
|---|---|---|
| 09:32 ET | 801 | 21.27 |
| 09:33 ET | 100 | 21.38 |
| 09:35 ET | 400 | 21.38 |
| 09:39 ET | 100 | 21.325 |
| 09:44 ET | 300 | 21.18 |
| 09:48 ET | 500 | 20.84 |
| 09:50 ET | 100 | 20.86 |
| 09:51 ET | 2070 | 21.12 |
| 09:53 ET | 100 | 20.9 |
| 09:55 ET | 700 | 20.99 |
| 10:00 ET | 2508 | 20.94 |
| 10:02 ET | 1399 | 20.78 |
| 10:04 ET | 200 | 20.765 |
| 10:08 ET | 100 | 20.74 |
| 10:09 ET | 306 | 20.76 |
| 10:11 ET | 200 | 20.78 |
| 10:15 ET | 1600 | 20.73 |
| 10:20 ET | 100 | 20.74 |
| 10:22 ET | 200 | 20.76 |
| 10:24 ET | 100 | 20.73 |
| 10:26 ET | 632 | 20.7981 |
| 10:27 ET | 200 | 20.79 |
| 10:29 ET | 457 | 20.71 |
| 10:31 ET | 800 | 20.73 |
| 10:33 ET | 1059 | 20.76 |
| 10:36 ET | 100 | 20.8 |
| 10:38 ET | 800 | 20.78 |
| 10:40 ET | 2863 | 20.81 |
| 10:42 ET | 3214 | 20.79 |
| 10:44 ET | 601 | 20.845 |
| 10:45 ET | 700 | 20.88 |
| 10:47 ET | 1100 | 20.895 |
| 10:49 ET | 100 | 20.92 |
| 10:51 ET | 800 | 20.93 |
| 10:54 ET | 100 | 20.93 |
| 10:56 ET | 100 | 20.91 |
| 10:58 ET | 800 | 21.07 |
| 11:00 ET | 119 | 21.0413 |
| 11:02 ET | 100 | 21.07 |
| 11:03 ET | 700 | 20.995 |
| 11:05 ET | 100 | 20.95 |
| 11:07 ET | 200 | 20.94 |
| 11:09 ET | 100 | 20.9 |
| 11:12 ET | 100 | 20.94 |
| 11:14 ET | 500 | 20.89 |
| 11:16 ET | 300 | 20.925 |
| 11:18 ET | 200 | 20.88 |
| 11:20 ET | 200 | 20.925 |
| 11:21 ET | 500 | 20.925 |
| 11:23 ET | 300 | 20.9 |
| 11:25 ET | 2373 | 20.98 |
| 11:27 ET | 1414 | 21.07 |
| 11:30 ET | 200 | 21.065 |
| 11:32 ET | 100 | 21.04 |
| 11:34 ET | 800 | 20.995 |
| 11:36 ET | 1014 | 21 |
| 11:39 ET | 100 | 20.95 |
| 11:41 ET | 1000 | 20.88 |
| 11:43 ET | 1200 | 20.9 |
| 11:45 ET | 300 | 20.89 |
| 11:50 ET | 100 | 20.915 |
| 11:52 ET | 400 | 20.91 |
| 11:54 ET | 2200 | 20.965 |
| 11:56 ET | 100 | 20.965 |
| 11:57 ET | 200 | 20.98 |
| 11:59 ET | 700 | 21.095 |
| 12:03 ET | 101 | 21.06 |
| 12:06 ET | 400 | 21.02 |
| 12:08 ET | 400 | 21.04 |
| 12:10 ET | 400 | 21.09 |
| 12:14 ET | 288 | 21.08 |
| 12:15 ET | 300 | 21.06 |
| 12:19 ET | 500 | 21.055 |
| 12:21 ET | 1124 | 21.07 |
| 12:24 ET | 100 | 21.06 |
| 12:26 ET | 819 | 21.1 |
| 12:28 ET | 300 | 21.08 |
| 12:30 ET | 400 | 21.08 |
| 12:32 ET | 300 | 21.12 |
| 12:33 ET | 200 | 21.1 |
| 12:37 ET | 400 | 21.11 |
| 12:39 ET | 100 | 21.12 |
| 12:42 ET | 200 | 21.14 |
| 12:44 ET | 424 | 21.1501 |
| 12:46 ET | 400 | 21.175 |
| 12:50 ET | 8255 | 20.96 |
| 12:53 ET | 100 | 20.97 |
| 12:55 ET | 600 | 21.02 |
| 01:00 ET | 100 | 21.01 |
| 01:04 ET | 958 | 20.93 |
| 01:06 ET | 200 | 20.99 |
| 01:08 ET | 100 | 20.97 |
| 01:09 ET | 900 | 21 |
| 01:11 ET | 100 | 20.995 |
| 01:13 ET | 100 | 20.995 |
| 01:18 ET | 1150 | 21.08 |
| 01:20 ET | 600 | 21.1 |
| 01:24 ET | 500 | 21.13 |
| 01:31 ET | 104 | 21.18 |
| 01:33 ET | 400 | 21.145 |
| 01:36 ET | 700 | 21.16 |
| 01:38 ET | 605 | 21.1 |
| 01:40 ET | 917 | 21.05 |
| 01:44 ET | 400 | 21.01 |
| 01:47 ET | 200 | 21.02 |
| 01:49 ET | 400 | 20.96 |
| 01:51 ET | 300 | 20.995 |
| 01:54 ET | 100 | 20.99 |
| 01:56 ET | 100 | 20.96 |
| 01:58 ET | 300 | 20.93 |
| 02:00 ET | 1410 | 20.93 |
| 02:09 ET | 500 | 20.89 |
| 02:12 ET | 300 | 20.89 |
| 02:14 ET | 800 | 20.89 |
| 02:20 ET | 500 | 20.885 |
| 02:21 ET | 300 | 20.86 |
| 02:23 ET | 600 | 20.86 |
| 02:25 ET | 600 | 20.92 |
| 02:30 ET | 500 | 20.9 |
| 02:32 ET | 550 | 20.925 |
| 02:34 ET | 700 | 20.92 |
| 02:38 ET | 400 | 20.89 |
| 02:39 ET | 200 | 20.915 |
| 02:41 ET | 1259 | 20.97 |
| 02:43 ET | 100 | 20.96 |
| 02:48 ET | 400 | 20.93 |
| 02:50 ET | 1499 | 20.99 |
| 02:56 ET | 550 | 20.98 |
| 02:57 ET | 500 | 20.985 |
| 02:59 ET | 200 | 20.99 |
| 03:01 ET | 666 | 20.99 |
| 03:03 ET | 500 | 20.995 |
| 03:06 ET | 700 | 21 |
| 03:08 ET | 1606 | 21.07 |
| 03:10 ET | 258 | 21.0999 |
| 03:12 ET | 573 | 21.07 |
| 03:14 ET | 500 | 21.07 |
| 03:15 ET | 400 | 21.06 |
| 03:17 ET | 100 | 21.06 |
| 03:19 ET | 500 | 21.08 |
| 03:21 ET | 300 | 21.075 |
| 03:26 ET | 500 | 21.1 |
| 03:28 ET | 1524 | 21.1 |
| 03:30 ET | 1600 | 21.11 |
| 03:32 ET | 2403 | 21.03 |
| 03:33 ET | 700 | 21.08 |
| 03:35 ET | 2432 | 21.079 |
| 03:37 ET | 1715 | 21.035 |
| 03:39 ET | 1493 | 21.07 |
| 03:42 ET | 9700 | 20.99 |
| 03:44 ET | 400 | 21.01 |
| 03:46 ET | 775 | 21.04 |
| 03:48 ET | 1100 | 21.04 |
| 03:50 ET | 1000 | 21.06 |
| 03:51 ET | 1495 | 21.055 |
| 03:53 ET | 999 | 21.11 |
| 03:55 ET | 3257 | 21.115 |
| 03:57 ET | 4652 | 21.115 |
| 04:00 ET | 51650 | 21.09 |
Nov 12, 2024
Kiniksa Pharmaceuticals to Present at Jefferies London Healthcare Conference, from 4:01PM ET on Tuesday Nov 12, 2024 by Dow Jones
4:01PM ET on Tuesday Nov 12, 2024 by Dow Jones
Nov 5, 2024
DJ Kiniksa Pharmaceuticals Is Maintained at Overweight by JP Morgan, from 11:10AM ET on Tuesday Nov 05, 2024 by Dow Jones
11:10AM ET on Tuesday Nov 05, 2024 by Dow Jones
Oct 30, 2024
DJ Kiniksa Pharmaceuticals Is Maintained at Outperform by Evercore ISI Group, from 11:07AM ET on Wednesday Oct 30, 2024 by Dow Jones
11:07AM ET on Wednesday Oct 30, 2024 by Dow Jones
Oct 29, 2024
DJ Kiniksa Pharmaceuticals Down Over 12%, on Pace for Largest Percent Decrease Since August 2021 -- Data Talk, from 11:09AM ET on Tuesday Oct 29, 2024 by Dow Jones
11:09AM ET on Tuesday Oct 29, 2024 by Dow JonesKiniksa Pharmaceuticals Reports Third Quarter 2024 Financial Results and Recent Portfolio Execution, from 7:30AM ET on Tuesday Oct 29, 2024 by Dow Jones
7:30AM ET on Tuesday Oct 29, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Kiniksa Pharmaceuticals International PLC | 1.5B | -133.1x | --- |
Dynavax Technologies Corp | 1.6B | 101.3x | --- |
CareDx Inc | 1.2B | -8.4x | --- |
BioCryst Pharmaceuticals Inc | 1.6B | -12.3x | --- |
Maravai LifeSciences Holdings Inc | 1.3B | -3.0x | --- |
MiMedx Group Inc | 1.4B | 18.6x | --- |
Company Information
Kiniksa Pharmaceuticals, Ltd. is a biopharmaceutical company. The Company is focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. Its portfolio of immune-modulating assets, ARCALYST (rilonacept), KPL-404 and mavrilimumab, are based on strong biologic rationale or validated mechanisms, target a spectrum of underserved cardiovascular and autoimmune conditions, and offer the potential for differentiation. The Company’s ARCALYST is interleukin-1alpha (IL-1α), and interleukin-1beta (IL-1β), cytokine trap for the treatment of recurrent pericarditis and reduction in risk of recurrence in adults and children. Its KPL-404 is an investigational monoclonal antibody inhibitor of CD40-CD154 interaction. The Company’s Mavrilimumab is an investigational monoclonal antibody inhibitor targeting granulocyte-macrophage colony stimulating factor receptor alpha (GM-CSFRα).
Contact Information
- Headquarters
- Clarendon House, 2 Church StreetHAMILTON, Bermuda HM11
- Phone
- ---
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Sanjiv Patel
- Chief Financial Officer, Senior Vice President
- Mark Ragosa
- Chief Operating Officer, Senior Vice President
- Eben Tessari
- Senior Vice President, Chief Commercial Officer
- Ross Moat
- Senior Vice President, Chief Medical Officer
- John Paolini
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.5B |
|---|---|
Revenue (TTM) | $384.1M |
Shares Outstanding | 72.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.26 |
EPS | $-0.16 |
Book Value | $6.23 |
P/E Ratio | -133.1x |
Price/Sales (TTM) | 4.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -6.83% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
